Introduction of malaria rapid diagnostic tests, new guidelines, and artemether-lumefantrine in Kenya: A cluster randomized trial

Introduction of malaria rapid diagnostic tests, new guidelines, and artemether-lumefantrine in Kenya: A cluster randomized trial

Bibliográfalaš dieđut
Váldodahkkit:	Skarbinski, J, Ouma, P, Causer, L, Kariuki, S, Barnwell, J, Alaii, J, de Oliveira, A, Zurovac, D, Larson, B, Snow, R, Rowe, A, Laserson, K, Akhwale, W, Slutsker, L, Hamel, M
Materiálatiipa:	Conference item
Almmustuhtton:	2007

Geahča maid

Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial.
Dahkki: Skarbinski, J, et al.
Almmustuhtton: (2009)

Clinical diagnosis of uncomplicated malaria in older children and adults in Kenya: An evidence base for newly introduced guidelines
Dahkki: Ouma, P, et al.
Almmustuhtton: (2007)

Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2008)

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.
Dahkki: Sudoi, R, et al.
Almmustuhtton: (2012)

Modeling the financial and clinical implications of malaria rapid diagnostic tests in the case-management of older children and adults in Kenya.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2008)

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya
Dahkki: Sudoi Raymond K, et al.
Almmustuhtton: (2012-02-01)

A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in children in western Kenya
Dahkki: Akhwale Willis S, et al.
Almmustuhtton: (2008-12-01)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2008)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2008)

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2005)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2007)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2007)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Dahkki: Ssekitooleko James, et al.
Almmustuhtton: (2008-09-01)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
Dahkki: Chanda Pascalina, et al.
Almmustuhtton: (2007-03-01)

Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya
Dahkki: Watsierah Carren A, et al.
Almmustuhtton: (2012-12-01)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
Dahkki: Wasunna, B, et al.
Almmustuhtton: (2008)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
Dahkki: Wasunna, B, et al.
Almmustuhtton: (2008)

The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2006)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
Dahkki: Zurovac Dejan, et al.
Almmustuhtton: (2008-02-01)

The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya.
Dahkki: Gitonga, C, et al.
Almmustuhtton: (2008)

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
Dahkki: van Vugt, M, et al.
Almmustuhtton: (2000)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
Dahkki: Sileshi Belew, et al.
Almmustuhtton: (2020-04-01)

Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether‐lumefantrine for uncomplicated malaria
Dahkki: Chotsiri, P, et al.
Almmustuhtton: (2019)

Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
Dahkki: Charles O. Obonyo, et al.
Almmustuhtton: (2022-06-01)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
Dahkki: Ali, S, et al.
Almmustuhtton: (2010)

The impact of a community awareness strategy on caregiver treatment seeking behaviour and use of artemether-lumefantrine for febrile children in rural Kenya
Dahkki: Wasunna, B, et al.
Almmustuhtton: (2015)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
Dahkki: Tarning, J, et al.
Almmustuhtton: (2022)

The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
Dahkki: Kangwana, B, et al.
Almmustuhtton: (2011)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
Dahkki: White, N, et al.
Almmustuhtton: (1999)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.
Dahkki: Sipilanyambe, N, et al.
Almmustuhtton: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
Dahkki: Sipilanyambe, N, et al.
Almmustuhtton: (2008)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
Dahkki: Tarning, J, et al.
Almmustuhtton: (2009)

Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
Dahkki: Tchaparian, E, et al.
Almmustuhtton: (2016)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
Dahkki: Snow Robert W, et al.
Almmustuhtton: (2008-01-01)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
Dahkki: Joel Tarning, et al.
Almmustuhtton: (2022-10-01)

Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
Dahkki: Walimbwa, S, et al.
Almmustuhtton: (2018)

Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2008)

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
Dahkki: Peto, TJ, et al.
Almmustuhtton: (2022)

The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
Dahkki: Beth P Kangwana, et al.
Almmustuhtton: (2011-05-01)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
Dahkki: White, N, et al.
Almmustuhtton: (1999)